KISS1 and neoplasm: KiSS-1-based treatments could be hypothetically simple if metastatic tumor cells express the KiSS-1 receptor; but the limitation is that most tumor cells do not express GPR54, so it could be a challenging aim for future researches to test multiple cancer treatment with KiSS-1 gene in the absence of its potential biomarker GPR54 (24).